Your browser doesn't support javascript.
loading
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
Einerhand, Sarah M H; Black, Anna J; Zargar, Homayoun; Fairey, Adrian S; Dinney, Colin P; Mir, Maria C; Krabbe, Laura-Maria; Cookson, Michael S; Jacobson, Niels-Erik; Montgomery, Jeffrey S; Vasdev, Nikhil; Yu, Evan Y; Xylinas, Evanguelos; Kassouf, Wassim; Dall'Era, Marc A; Sridhar, Srikala S; McGrath, Jonathan S; Aning, Jonathan; Shariat, Shahrokh F; Wright, Jonathan L; Thorpe, Andrew C; Morgan, Todd M; Holzbeierlein, Jeff M; Bivalacqua, Trinity J; North, Scott; Barocas, Daniel A; Lotan, Yair; Grivas, Petros; Garcia, Jorge A; Stephenson, Andrew J; Shah, Jay B; Daneshmand, Siamak; Zargar-Shoshtari, Kamran; Spiess, Philippe E; van Rhijn, Bas W G; Black, Peter C; Mertens, Laura S.
Afiliación
  • Einerhand SMH; Department of Surgical Oncology (Urology), The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Black AJ; Vancouver Prostate Centre, Vancouver, Canada.
  • Zargar H; Department of Urology, Western Health, Melbourne, Australia.
  • Fairey AS; USC/Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, CA, USA.
  • Dinney CP; University of Alberta, Edmonton, AB, Canada.
  • Mir MC; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.
  • Krabbe LM; Department of Urology, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain.
  • Cookson MS; Department of Urology, University of Münster, Münster, Germany.
  • Jacobson NE; Department of Urology, University of Oklahoma College of Medicine, Oklahoma City, OK, USA.
  • Montgomery JS; University of Alberta, Edmonton, AB, Canada.
  • Vasdev N; Department of Urology, University of Michigan Health System, Ann Arbor, MI, USA.
  • Yu EY; Hertfordshire and Bedfordshire Urological Cancer Centre, Department of Urology, Lister Hospital, Stevenage, UK.
  • Xylinas E; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK.
  • Kassouf W; Division of Oncology, Department of Medicine, University of Washington School of Medicine and Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Dall'Era MA; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital New York, New York, NY, USA.
  • Sridhar SS; Department of Surgery (Division of Urology), McGill University Health Centre, Montreal, QC, Canada.
  • McGrath JS; Department of Urology, David Medical Center, University of California at David, Sacramento, CA, USA.
  • Aning J; Princess Margaret Hospital, Toronto, ON, Canada.
  • Shariat SF; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, UK.
  • Wright JL; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK.
  • Thorpe AC; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, UK.
  • Morgan TM; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital New York, New York, NY, USA.
  • Holzbeierlein JM; Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.
  • Bivalacqua TJ; Division of Oncology, Department of Medicine, University of Washington School of Medicine and Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • North S; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK.
  • Barocas DA; Department of Urology, University of Michigan Health System, Ann Arbor, MI, USA.
  • Lotan Y; Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Grivas P; Division of Urology, University of Pennsylvania, Pennsylvania, PA, USA.
  • Garcia JA; Cross Cancer Institute, Edmonton, AB, Canada.
  • Stephenson AJ; Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Shah JB; Department of Urology, University of Texas Southern Medical Center, Dallas, TX, USA.
  • Daneshmand S; Division of Oncology, Department of Medicine, University of Washington School of Medicine and Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Zargar-Shoshtari K; Department of Medicine, Case Comprehensive Cancer Center, Cleveland, USA.
  • Spiess PE; Division of Urology, Rush University Medical Center, Chicago, IL, USA.
  • van Rhijn BWG; Department of Urology, Stanford University School of Medicine, Stanford, CA, USA.
  • Black PC; USC/Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, CA, USA.
  • Mertens LS; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
World J Urol ; 40(11): 2707-2715, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36169695
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Cistectomía Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: World J Urol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Cistectomía Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: World J Urol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos